Chasing the Tortoise

By Dan Primack — 12 years ago

Thomson Financial has compiled a wide array of market data for August, but there is a unifying theme: The month was slow. Very, very slow. Here is the Capital Markets Snapshot: Here is the M&A Snapshot, which includes breakout data for financial sponsor-backed transactions. Here are some of the lowlights, for those to lazy to download: […]

Continue

Hospitalist Co. Files for IPO

By PEHub Administrator — 12 years ago

IPC The Hospitalist Company Inc., a North Hollywood, Calif.-based network of hospitalist physicians, has filed for a $105 million IPO. It plans to trade on the NYSE under ticker symbol IPCM, with Credit Suisse and Jefferies & Co. serving as co-lead underwriters. Shareholders include Bank of America Ventures (30.92% pre-IPO stake), Morgenthaler Ventures (25.13%), Bessemer […]

Continue

Merrion Pharma Sets IPO Price

By PEHub Administrator — 12 years ago

Merrion Pharmaceuticals Ltd., a Dublin, Ireland-based developer of oral-dosage forms of drugs with poor bioavailability, has set its IPO terms to four million American depository shares being offered at between $10 and $12 per share. It plans to trade on both the Nasdaq and IEX under ticker symbol MERR. Punk, Ziegel & Co. is serving as […]

Continue

Anacor Files for IPO

By PEHub Administrator — 12 years ago

Anacor Pharmaceuticals Inc., a Palo Alto, Calif.-based developer of topical therapeuticals, has filed for a $57.5 million IPO. It plans to trade on the Nasdaq under ticker symbol ANAC, with Morgan Stanley and Cowen & Co. serving as co-lead underwriters. VC backers include Rho Ventures, Venrock, Red Abbey Venture Partners and Aberdare Ventures. www.anacor.com

Continue

ARYx Files for IPO

By PEHub Administrator — 12 years ago

NEW YORK (AP) – Biopharmaceutical company Aryx Therapeutics Inc. plans an initial public offering of its common stock, according to a regulatory filing Thursday with the Securities and Exchange Commission. Aryx did not disclose the expected number or price range of shares to be offered, but indicated the offering price could total up to $86.3 […]

Continue

Convio Files for IPO

By PEHub Administrator — 12 years ago

Convio Inc., an Austin, Texas-based provider of online constituent relationship management solutions for nonprofit organizations, has filed for an $86.25 million IPO. It plans to trade on the Nasdaq under ticker symbol CNVO, with Goldman Sachs serving as lead underwriter. Convio has raised over $36 million in VC funding from firms like Granite Ventures (21% […]

Continue

Oaktree Joins Hung Bridge Club

By Dan Primack — 12 years ago

Oaktree Capital Management has decided to help loosen some of the “hung bridges” that are currently strangling Wall Street. Sources tell me that the Los Angeles-based firm is raising between $3 billion and $5 billion for a new fund that will buy up LBO-related debt that banks have been unable to place. It is being […]

Continue

Tensar Files for IPO

By PEHub Administrator — 12 years ago

Tensar Corp., an Atlanta-based construction services company, has filed for a $201.25 million IPO. It plans to trade on the NYSE under ticker symbol TXC, with Lehman Brothers, Credit Suisse and Merrill Lynch serving as co-lead underwriters. Tensar shareholders include Arcapita (86.3%), Electra Private Equity (6.3%) and KRG Capital Partners. Tensar offers nontraditional products and […]

Continue

A Preemptive Price Reduction

By Dan Primack — 12 years ago

We now have a second take-private buyout whose price was reduced due to credit market woes. Actually, it seems to have been the first one. More than a month before Home Depot Supply became a business page soap opera, Platinum Equity cut its offer for metal processor Ryerson Inc. (NYSE: RYI) from $37.50 per share to […]

Continue

Bulls & Bears

By Dan Primack — 12 years ago

Email of the Day comes from Dale: “Dan, you’ve been reliably bearish over the past two years, insisting that the credit markets would eventually stop providing such cheap debt to private equity firms. Then once it finally happens, you begin talking ‘bull’ about how the market will survive, deals will get done, etc. I’ve concluded […]

Continue

Better Than The S&P 500

By Dan Primack — 12 years ago

I have issued exactly one piece of investment advice since the credit crunch began six weeks ago: Buy stock in publicly-traded companies that have already agreed to go private. One or two might sour, but the overall “index” will generate positive returns. If you did so, I accept thanks in the form of story leads and/or […]

Continue

Sonics Files for IPO

By PEHub Administrator — 12 years ago

Sonics Inc., a Mountain View, Calif.-based provider of interconnect solutions that manage on-chip communications in SoCs devices has filed for an $80 million IPO. It plans to trade on the Nasdaq under ticker symbol SNCS, with UBS serving as lead underwriter. Sonics has raised around $62 million in VC funding from firms like InveStar Capital […]

Continue

Fundless Sponsors Convene Roundtable

By Joshua Payne — 12 years ago

Fundless equity sponsors are the ultimate gamblers in the private equity universe. Sourcing and vetting deals without any committed capital, lining up financial sponsors on a deal-by-deal basis, and paying out of pocket for office space and due diligence, they roll the dice with each transaction. “We have to make it work. Fundless sponsors live […]

Continue

We Have An Agreement

By Dan Primack — 12 years ago

Today’s top news is that a tentative agreement has been reached by the feuding Hatfields, McCoys, Dimons, Fulds, Langones and every other party involved in the Home Depot Supply sale. The original $10.3 billion price-tag has been knocked to $8.5 billion, with Home Depot expected to retain a 12.5% position. Three quick reactions: 1. The […]

Continue

MedAssets Files for IPO

By PEHub Administrator — 12 years ago

MedAssets Inc., an Alpharetta, Ga.-based provider of software to improve operating margin and cashflow for hospitals and health systems, has filed for a $230 million IPO. It plans to trade on the Nasdaq under vticker symbol MDAS, with Morgan Stanley and Lehman Brothers serving as co-lead underwriters. MedAssets shareholders include Galen Partners (23.2% pre-IPO stake), […]

Continue

Working Weekend

By Dan Primack — 12 years ago

[Monday update] It looks like negotiations on the Home Depot Supply sale will drag into the weekend, as the three-headed monster continues to bicker with itself. One head is Home Depot, which was the first to blink by entertaining the notion of a $1.2 billion price reduction. It seems that its entertainment is serious enough to be deemed an upper-crust dinner […]

Continue

Precision Therapeutics Files for IPO

By PEHub Administrator — 12 years ago

Precision Therapeutics Inc., a Pittsburgh-based oncology services company, has filed for an $80.5 million IPO. It plans to trade on the Nasdaq, with JPMorgan and Piper Jaffray serving as co-lead underwriters. Precision Therapeutics has raised around $84 million in VC funding since 1996, from firms like Adams Capital Management (39.1% pre-IPO stake), Quaker bioVentures (21.5%), […]

Continue

ZARS Sets IPO Terms

By PEHub Administrator — 12 years ago

ZARS Inc., a Salt Lake City-based developer of non-invasive drug delivery technologies, has set its IPO terms to five million common shares being offered at between $14 and $16 per share. It would have an initial market cap of approximately $262 million, were it to price at the high end of its range. ZARS plans […]

Continue